Summary of this article
Sudeep Pharma IPO is scheduled to close for subscription on November 25.
Sudeep Pharma IPO share allotment status will be finalised on November 26.
Sudeep Pharma Ltd shares will list on the NSE and BSE on November 28.
Sudeep Pharma IPO Subscription: The subscription window of Sudeep Pharma Ltd’s initial public offering (IPO) is scheduled to close on November 25. The pharmaceutical company’s public issue saw sustained demand on the third day of subscription.
On the third day of subscription, Sudeep Pharma IPO has been booked over 20 times so far. Despite the sustained demand indicated by new bids, the grey market premium for the company’s shares witnessed a slight decline on the final day of bidding.
Sudeep Pharma IPO Subscription On Day 3
On the third day of subscription, Sudeep Pharma IPO was subscribed 20.37 times. Cumulatively, the issue received bids for 215.25 million shares compared to the 10.56 million shares offered for subscription.
On all three days of subscription, the non-institutional investor (NII) category led the demand for the pharmaceutical company’s shares. NIIs booked their quota in the public issue 52.25 times as they bid for 118.28 million shares compared to the 2.26 million shares reserved for them.
Sudeep Pharma IPO has been booked 9.31 times by retail individual investors (RIIs) so far. RIIs have applied for 49.16 million shares against the 5.28 million shares set aside for them.
Qualified institutional buyers (QIBs) booked their quota in the public issue 15.84 times. QIBs applied for 47.8 million shares compared to the 3.01 million shares set aside for the category.
Sudeep Pharma IPO GMP
Sudeep Pharma IPO grey market premium (GMP) declined on the final day of bidding from Rs 91 per share to Rs 71 per share as per several websites which monitor the demand for shares of unlisted companies. Sudeep Pharma shares are expected to list with gains of 11.97 per cent at Rs 664 per share.
Sudeep Pharma IPO Issue Size
Sudeep Pharma Ltd seeks to raise Rs 895 crore from its public issue. The pharmaceutical company’s issue size comprises a fresh issuance of 1.6 million shares amounting to Rs 95 crore and an offer for sale of 13.5 million shares aggregating to Rs 800 crore.
Sudeep Pharma IPO Price Band
Sudeep Pharma IPO price band was set at Rs 563 to Rs 593 per share. The minimum lot size for retail individual investors was fixed at 25 shares, which aggregates to an investment of Rs 14,825 .
Sudeep Pharma IPO: Subscription Dates and Listing Date
Sudeep Pharma IPO subscription window was open from November 21 to November 25. The basis of allotment for Sudeep Pharma IPO will be announced on November 26. Sudeep Pharma Ltd will issue refunds for unsuccessful applicants on November 27. Sudeep Pharma Ltd shares are scheduled to list on the bourses on November 28.
Sudeep Pharma: Financials
Sudeep Pharma’s total income for the June quarter of FY26 stood at Rs 130.08 crore. The excipient manufacturer’s net profit and net worth for the June quarter were Rs 31.27 crore and Rs 688.32 crore, respectively.
In FY25, the pharma company posted a total income of Rs 511.33, increasing by over 9 per cent from Rs 465.38 crore in the preceding fiscal. The excipient maker’s net profit for FY25 stood at Rs 138.69 crore, growing by more than 4 per cent from Rs 133.15 crore in the preceding fiscal. The net worth of the company surged by more than 38 per cent to Rs 497.53 crore in FY25 compared to Rs 359.07 crore in FY24.
Sudeep Pharma IPO: Registrar
ICICI Securities Ltd is the book-running lead manager for Sudeep Pharma IPO, and the registrar for the issue is MUFG Intime India Pvt Ltd.
Sudeep Pharma: Promoters
Promoters of the pharmaceutical company are set to pare their stake in the public issue. The selling promoters include Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani HUF, Riva Resources Private Ltd, and Bhayani Family Trust. The shareholding of the selling promoters will reduce from 89.37 per cent to 76.15 per cent post the issue.
Sudeep Pharma IPO: Objective
Sudeep Pharma Ltd will use the money raised via the public issue for procuring machinery for its production line located in Nandesari, Gujarat. The proceeds will also be used by the pharmaceutical company for general corporate purposes.
About Sudeep Pharma
Sudeep Pharma Ltd is a maker of pharmaceutical excipients, food-grade minerals, and speciality nutrition ingredients. The company makes over 200 high-purity mineral-based products which are used in the pharmaceutical, food and beverage, nutraceutical, and personal care industries.
